Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Non-cash Items (2019 - 2023)

Korro Bio (KRRO) has disclosed Non-cash Items for 4 consecutive years, with $9.5 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Non-cash Items rose 116.09% year-over-year to $9.5 million, compared with a TTM value of $9.5 million through Sep 2023, up 116.09%, and an annual FY2022 reading of $9.1 million, down 76.7% over the prior year.
  • Non-cash Items was $9.5 million for Q3 2023 at Korro Bio, down from $12.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $171.4 million in Q4 2020 and bottomed at $789000.0 in Q2 2022.
  • Average Non-cash Items over 4 years is $27.9 million, with a median of $12.5 million recorded in 2023.
  • The sharpest move saw Non-cash Items tumbled 92.18% in 2022, then soared 1488.85% in 2023.
  • Year by year, Non-cash Items stood at $171.4 million in 2020, then plummeted by 77.18% to $39.1 million in 2021, then crashed by 76.7% to $9.1 million in 2022, then increased by 3.73% to $9.5 million in 2023.
  • Business Quant data shows Non-cash Items for KRRO at $9.5 million in Q3 2023, $12.5 million in Q2 2023, and $17.6 million in Q1 2023.